Tamarack Capital Management

Tamarack Capital Management as of March 31, 2013

Portfolio Holdings for Tamarack Capital Management

Tamarack Capital Management holds 25 positions in its portfolio as reported in the March 2013 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p 500 Etf (SPY) 25.8 $63M 400k 156.67
Greatbatch 7.2 $17M 584k 29.87
Pacira Pharmaceuticals (PCRX) 6.4 $16M 537k 28.86
Elan Corporation 5.5 $13M 1.1M 11.80
Haemonetics Corporation (HAE) 5.2 $13M 300k 41.66
Dex (DXCM) 5.1 $12M 737k 16.72
Alkermes (ALKS) 5.0 $12M 507k 23.70
MedAssets 4.0 $9.8M 510k 19.25
Merck & Co (MRK) 3.6 $8.8M 200k 44.20
RTI Biologics 3.4 $8.2M 2.1M 3.93
Perrigo Company 2.9 $7.1M 60k 118.74
AtriCure (ATRC) 2.9 $6.9M 872k 7.92
Spectranetics Corporation 2.6 $6.3M 339k 18.53
Laboratory Corp. of America Holdings (LH) 2.6 $6.2M 69k 90.20
CareFusion Corporation 2.3 $5.6M 160k 34.99
Volcano Corporation 2.2 $5.4M 243k 22.26
Vocera Communications 2.0 $4.8M 208k 23.00
Accuray Incorporated (ARAY) 2.0 $4.8M 1.0M 4.64
Teva Pharmaceutical Industries (TEVA) 1.8 $4.4M 110k 39.68
Johnson & Johnson (JNJ) 1.7 $4.1M 50k 81.54
Solta Medical 1.6 $3.9M 1.8M 2.20
D Fluidigm Corp Del (LAB) 1.6 $3.9M 209k 18.51
Bruker Corporation (BRKR) 1.2 $2.9M 150k 19.10
Teva Pharmaceutical Industries (TEVA) 0.8 $2.0M 50k 39.68
ViroPharma Incorporated 0.8 $2.0M 80k 25.16